findmyKOL
Clinical trialNCT00979212CompletedPhase 2Interventional

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

SponsorRadiation Therapy Oncology GroupEnrollment71Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mercy Cancer Center at Mercy San Juan Medical Center

    Carmichael, California, United States

  • Radiological Associates of Sacramento Medical Group, Incorporated

    Sacramento, California, United States

  • Penrose Cancer Center at Penrose Hospital

    Colorado Springs, Colorado, United States

  • Lucille P. Markey Cancer Center at University of Kentucky

    Lexington, Kentucky, United States

  • Ccop - Ochsner

    New Orleans, Louisiana, United States

  • Greenebaum Cancer Center at University of Maryland Medical Center

    Baltimore, Maryland, United States

  • St. Agnes Hospital Cancer Center

    Baltimore, Maryland, United States

  • Cancer Institute at St. Joseph Medical Center

    Towson, Maryland, United States

  • Boston University Cancer Research Center

    Boston, Massachusetts, United States

  • Fairview Southdale Hospital

    Edina, Minnesota, United States

  • Virginia Piper Cancer Institute at Abbott - Northwestern Hospital

    Minneapolis, Minnesota, United States

  • Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis

    St Louis, Missouri, United States

  • Methodist Estabrook Cancer Center

    Omaha, Nebraska, United States

  • Nyu Cancer Institute at New York University Medical Center

    New York, New York, United States

  • James P. Wilmot Cancer Center at University of Rochester Medical Center

    Rochester, New York, United States

  • Summa Center for Cancer Care at Akron City Hospital

    Akron, Ohio, United States

  • Charles M. Barrett Cancer Center at University Hospital

    Cincinnati, Ohio, United States

  • Cleveland Clinic Taussig Cancer Center

    Cleveland, Ohio, United States

  • Natalie Warren Bryant Cancer Center at St. Francis Hospital

    Tulsa, Oklahoma, United States

  • Bryn Mawr Hospital

    Bryn Mawr, Pennsylvania, United States

  • Adams Cancer Center

    Gettysburg, Pennsylvania, United States

  • Cherry Tree Cancer Center

    Hanover, Pennsylvania, United States

  • Cancer Center of Paoli Memorial Hospital

    Paoli, Pennsylvania, United States

  • Albert Einstein Cancer Center

    Philadelphia, Pennsylvania, United States

  • Fox Chase Cancer Center - Philadelphia

    Philadelphia, Pennsylvania, United States

  • Kimmel Cancer Center at Thomas Jefferson University - Philadelphia

    Philadelphia, Pennsylvania, United States

  • Mcglinn Family Regional Cancer Center at Reading Hospital and Medical Center

    Reading, Pennsylvania, United States

  • Lankenau Cancer Center at Lankenau Hospital

    Wynnewood, Pennsylvania, United States

  • York Cancer Center at Apple Hill Medical Center

    York, Pennsylvania, United States

  • Medical College of Wisconsin Cancer Center

    Milwaukee, Wisconsin, United States

  • Veterans Affairs Medical Center - Milwaukee

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2011
Primary completion
31 Dec 2015
Completion
20 May 2022
Last update posted
15 Jun 2022
Registered enrollment
71
Registry id
NCT00979212

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.